Preliminary results of ENCORE 601, a phase 1 b/2, open-label study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Johnson, M. L.; Adjei, A. A.; Ramalingam, S. S.; Janne, P. A.; Dominguez, G.; Gabrilovich, D.; Deleon, L.; Hasapidis, J. L.; Diede, S. J.; Ordentlich, P.; Hellmann, M. D. |
| Abstract Title: | Preliminary results of ENCORE 601, a phase 1 b/2, open-label study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Language: | English |
| ACCESSION: | WOS:000404711507114 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.e20659 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e20659 -- Source: Wos |
